Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Depreciation and Depletion (2019 - 2025)

Historic Depreciation and Depletion for Volitionrx (VNRX) over the last 7 years, with Q3 2025 value amounting to $242093.0.

  • Volitionrx's Depreciation and Depletion fell 1056.65% to $242093.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 929.15%. This contributed to the annual value of $1.1 million for FY2024, which is 0.0% changed from last year.
  • Per Volitionrx's latest filing, its Depreciation and Depletion stood at $242093.0 for Q3 2025, which was down 1056.65% from $246677.0 recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Depreciation and Depletion registered a high of $307768.0 during Q4 2023, and its lowest value of $173018.0 during Q4 2021.
  • In the last 5 years, Volitionrx's Depreciation and Depletion had a median value of $246677.0 in 2025 and averaged $246306.0.
  • Per our database at Business Quant, Volitionrx's Depreciation and Depletion surged by 4953.62% in 2021 and then tumbled by 1126.23% in 2025.
  • Volitionrx's Depreciation and Depletion (Quarter) stood at $173018.0 in 2021, then surged by 38.96% to $240432.0 in 2022, then rose by 28.01% to $307768.0 in 2023, then decreased by 7.67% to $284176.0 in 2024, then fell by 14.81% to $242093.0 in 2025.
  • Its last three reported values are $242093.0 in Q3 2025, $246677.0 for Q2 2025, and $246248.0 during Q1 2025.